TER

Business profile & competitive position

Teradyne, Inc. (TER) operates inside the Technology sector, specifically the Semiconductors industry, but its business model stretches beyond chip design. The company is a global provider of automated test equipment (ATE) used to test semiconductors, wireless products, data storage, silicon photonics, and complex electronic systems. Its end markets include consumer electronics, automotive, computing, communications, and aerospace and defense. In addition, Teradyne runs a robotics segment built around collaborative robotic arms and autonomous mobile robots, which are sold to manufacturing, logistics, and industrial customers looking to improve throughput and lower operating costs.

The company’s reported profitability metrics help illustrate the quality of that franchise. As of the current snapshot, Teradyne carries a net margin of 25.8% and a return on equity of 38.0%. Those figures are not guarantees of future performance, but they do point to above-average pricing power and capital efficiency for a capital-equipment and hardware-oriented business. A 25.8% net margin suggests the company converts a meaningful share of revenue into bottom-line profit, while a 38.0% ROE indicates that management has historically generated strong returns on the equity base. At the same time, the model is not immune to down cycles: semiconductor test demand is tied to customer capital expenditure plans, and robotics sales depend on industrial automation budgets. The diversified portfolio—ATE, robotics, and a recently formed Product Test segment—offers multiple revenue levers, but it also means Teradyne is exposed to several end-market cycles at once.

Financial posture

Teradyne currently commands a market capitalization of $60.0 billion and trades at a price-to-earnings ratio of 52.4. That multiple is materially above the long-term average for the broader market and signals that investors are pricing in sustained earnings growth. Whether that premium is justified depends on the trajectory of AI-related test demand, robotics adoption, and the pace of new product releases. The company’s profitability profile is strong: net margin of 25.8% and ROE of 38.0% sit well above typical levels for industrial and test-equipment firms. The stock also carries a beta of 1.75, meaning it has historically been roughly 75% more volatile than the overall market and tends to magnify sector-wide swings. At the current snapshot, the stock is at $383.85 with an RSI of 46.9 and a 50-day exponential moving average of $386.40, placing the price close to a widely watched short-term trend measure around the earnings window.

Strategic priorities & outlook

Teradyne’s most recent SEC 10-K filing outlines a strategy built on three operational priorities: profitably growing revenue and market share through differentiated products, maintaining a balanced capital allocation program between organic/inorganic investment and shareholder returns, and continuing targeted investment in AI-related applications and vertically integrated producer (VIP) customers, with benefits expected to continue into 2026.

A concrete execution example is the formation of MultiLane Test Products, a joint venture with MultiLane aimed at the AI data center equipment market, which Teradyne expects to close in the first half of 2026. The company also reorganized its reporting structure: effective March 2025, it created the Product Test division as a new reportable segment to capture operational synergies across production board test, defense and aerospace, and wireless test businesses. In 2025, Semiconductor Test revenue grew considerably on AI-driven demand in networking and VIP compute, while Product Test growth was led primarily by defense and aerospace applications.

Two concentration figures stand out from the filing. International sales represented 89% of consolidated revenues in 2025, and the five largest direct customers accounted for 44% of consolidated revenues. That international footprint means currency translation and cross-border trade policy are meaningful variables, while customer concentration creates revenue leverage to a handful of large buyers. The dual push into AI data center testing and defense/aerospace applications also gives the company two different growth vectors, each with its own macro sensitivity.

Macro & geopolitical exposure

Because Teradyne sits in the Semiconductor industry, its macro exposure is shaped by the global chip capital-spending cycle rather than by retail or commodity demand alone. Semiconductor test equipment demand rises when fabs, chip designers, and OEMs expand capacity or introduce advanced packages; it contracts quickly when inventories build and capex budgets are cut. The business is also sensitive to U.S.-China technology tensions, export controls on advanced semiconductors, and any restrictions on selling test and measurement gear into certain geographies or end markets. With 89% of revenue coming from international markets, currency swings—particularly a stronger U.S. dollar—can pressure reported results.

The robotics segment ties Teradyne to industrial automation and logistics capital budgets, which move with manufacturing PMI trends and e-commerce fulfillment spending. The defense and aerospace exposure flowing through Product Test means government appropriations and procurement timing can influence orders. Robotics and ATE supply chains also rely on specialized electronic components, motors, sensors, and software, so broader supply chain constraints or tariffs on precision hardware could affect margins and lead times. Finally, because chip production and advanced packaging are heavily concentrated in Taiwan and South Korea, any geopolitical disruption in those regions could indirectly affect Teradyne’s customers and their ordering patterns.

Recent developments

Teradyne has been active in the news lately. On 2026-10-12, Zacks (zacks.com) published “Teradyne Boosts Test Portfolio With Titan HP: Can It Beat KLAC & COHU?,” framing the new platform in the context of competition with KLA and Cohu. The same day, Business Wire (businesswire.com) reported that Teradyne “Introduces UltraFLEXplus S Series for Edge AI Applications,” highlighting a push into edge-AI test demand. On 2026-10-10, The Motley Fool (fool.com) included Teradyne in “5 Companies Fighting for Control of the Next Robotics Boom,” noting its robotics footprint alongside other automation players. On 2026-10-09, Defense World (defenseworld.net) reported that Bell Asset Management Ltd bought 7,608 shares in Teradyne, a small but real institutional flow update heading into the October earnings report.

Earnings behavior & post-earnings drift

Teradyne has exceeded the official consensus estimate in every one of the last eight reported quarters, for a 100% beat rate over that span. The average earnings surprise across those quarters is 15.3%, and the average 5-day post-earnings price move is 16.43% to the upside. Those numbers point to a pattern of strong execution relative to analyst models, followed on average by positive price drift once the market digests the report.

The last four reported quarters show how uneven that drift can be:

• On 2026-07-28, Teradyne reported EPS of $2.47 versus an estimate of $2.09, an 18.2% beat. The stock fell 0.39% the next day but rallied 25.86% over the following five sessions.
• On 2026-04-28, EPS came in at $2.56 against a $2.11 estimate, a 21.3% beat. The market reacted sharply: the stock dropped 19.41% the next day and was down 6.06% over the next five sessions.
• On 2026-02-02, EPS was $1.80 compared with a $1.38 estimate, a 30.4% beat. Shares rose 13.41% the next day and 24.24% over the following five trading days.
• On 2025-10-28, EPS of $0.85 beat the $0.79 estimate by 7.6%. The stock gained 20.47% the next day and 21.66% over the next five sessions.

The next earnings release is scheduled for 2026-10-27 after the close, with a consensus EPS estimate of $2.08. The upcoming report will test whether Teradyne can extend its 100% beat streak and whether the stock follows its historical upward post-earnings drift or repeats the kind of adverse reaction seen after the April 2026 report.

For a deeper view of the risk/reward setup heading into the October 27, 2026 earnings release, including updated institutional rating distributions, price-target dispersion, and sell-side revisions, readers can review the full institutional verdict on the stock.